HomeMDNAF • OTCMKTS
add
Medicenna Therapeutics Corp
Previous close
$0.64
Day range
$0.60 - $0.64
Year range
$0.57 - $1.94
Market cap
70.38M CAD
Avg Volume
28.97K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.72M | 42.94% |
Net income | 1.19M | 108.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.71M | -42.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.84M | 46.25% |
Total assets | 28.38M | 48.33% |
Total liabilities | 9.29M | -33.39% |
Total equity | 19.10M | — |
Shares outstanding | 83.38M | — |
Price to book | 2.66 | — |
Return on assets | -47.17% | — |
Return on capital | -77.52% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.19M | 108.54% |
Cash from operations | -5.00M | -3.12% |
Cash from investing | 0.00 | — |
Cash from financing | -19.00K | — |
Net change in cash | -5.16M | -8.02% |
Free cash flow | -3.13M | 29.45% |
About
Founded
2015
Headquarters
Website
Employees
18
